{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:10:01Z","timestamp":1768313401294,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Gulhane Military Medical Academy","award":["AR-2013\/03"],"award-info":[{"award-number":["AR-2013\/03"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.schres.2018.12.015","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T16:07:01Z","timestamp":1545581221000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["l-Arginine metabolism before and after 10\u202fweeks of antipsychotic treatment in first-episode psychotic patients"],"prefix":"10.1016","volume":"206","author":[{"given":"Beyazit","family":"Garip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-4207","authenticated-orcid":false,"given":"Hakan","family":"Kayir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozcan","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2018.12.015_bb0010","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.biopsych.2013.09.037","article-title":"Autoimmunity, inflammation, and psychosis: a search for peripheral markers","volume":"75","author":"Bergink","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2018.12.015_bb0015","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/0006-3223(92)90157-U","article-title":"Is plasma serine a marker for psychosis?","volume":"31","author":"Carl","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10408398.2011.651177","article-title":"Sex hormones and macronutrient metabolism","volume":"55","author":"Comitato","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.schres.2018.12.015_bb0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000026478","article-title":"Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia","volume":"37","author":"Das","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.schres.2018.12.015_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4306\/pi.2008.5.4.203","article-title":"Peripheral amino acid levels in schizophrenia and antipsychotic treatment","volume":"5","author":"De Luca","year":"2008","journal-title":"Psychiatry Investig."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0040","first-page":"14","article-title":"Negatif semptomlari degerlendirme olceginin g\u00fcvenirli\u011fi ve gecerliligi","volume":"4","author":"Erkoc","year":"1991","journal-title":"Dusunan Adam"},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0045","first-page":"20","article-title":"Pozitif semptomlari degerlendirme olceginin g\u00fcvenirli\u011fi ve gecerliligi","volume":"4","author":"Erkoc","year":"1991","journal-title":"Dusunan Adam"},{"issue":"4","key":"10.1016\/j.schres.2018.12.015_bb0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.32.4.730","article-title":"Evidence for a difference in nitric oxide biosynthesis between healthy women and men","volume":"32","author":"Forte","year":"1998","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.schres.2018.12.015_bb0055","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.euroneuro.2016.10.013","article-title":"Agmatine, a potential novel therapeutic strategy for depression","volume":"26","author":"Freitas","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Pt 1","key":"10.1016\/j.schres.2018.12.015_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3160247","article-title":"Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine","volume":"316","author":"Galea","year":"1996","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pbb.2010.11.009","article-title":"The treatment of cognitive impairment in schizophrenia","volume":"99","author":"Goff","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"11","key":"10.1016\/j.schres.2018.12.015_bb0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2018.12.015_bb0075","series-title":"Annals of the New York Academy of Sciences","first-page":"445","article-title":"Plasma agmatine and platelet imidazoline receptors in depression","volume":"881","author":"Halaris","year":"1999"},{"issue":"7","key":"10.1016\/j.schres.2018.12.015_bb0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamapsychiatry.2013.1292","article-title":"Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Hallak","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2018.12.015_bb0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III-the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0090","first-page":"4","article-title":"Glutamatergic theories of schizophrenia","volume":"47","author":"Javitt","year":"2010","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"issue":"10","key":"10.1016\/j.schres.2018.12.015_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2018.12.015_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2215-0366(15)00098-X","article-title":"d-Serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial","volume":"2","author":"Kantrowitz","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2004.05.029","article-title":"Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury","volume":"189","author":"Kim","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.schres.2018.12.015_bb0110","series-title":"American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders \u2013 Turkish","author":"Koroglu","year":"2007"},{"issue":"3","key":"10.1016\/j.schres.2018.12.015_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2018.12.015_bb0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","article-title":"Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function","volume":"62","author":"Krystal","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"64","key":"10.1016\/j.schres.2018.12.015_bb0125","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1038\/tp.2016.144","article-title":"Altered brain arginine metabolism in schizophrenia","volume":"6","author":"Liu","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"17","key":"10.1016\/j.schres.2018.12.015_bb0130","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1111\/bph.13222","article-title":"Ketamine and phencyclidine: the good, the bad and the unexpected","volume":"172","author":"Lodge","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCO.0b013e3283412343","article-title":"Protein metabolism in women and men: similarities and disparities","volume":"14","author":"Markofski","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-11-26","article-title":"Reduced antioxidant defense in early onset first-episode psychosis: a case-control study","volume":"11","author":"Mic\u00f3","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2018.12.015_bb0150","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/schbul\/sbs075","article-title":"Capturing the angel in \u201cangel dust\u201d: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans","volume":"38","author":"Moghaddam","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"6 Suppl 2","key":"10.1016\/j.schres.2018.12.015_bb0155","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.schres.2018.12.015_bb0160","doi-asserted-by":"crossref","first-page":"2579S","DOI":"10.3945\/jn.115.226621","article-title":"Arginine metabolism revisited","volume":"146","author":"Morris","year":"2016","journal-title":"J. Nutr."},{"key":"10.1016\/j.schres.2018.12.015_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2015.00139","article-title":"Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects","volume":"6","author":"Nasyrova","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.schres.2018.12.015_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuint.2017.05.006","article-title":"Therapeutic potential of agmatine for CNS disorders","volume":"108","author":"Neis","year":"2017","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.schres.2018.12.015_bb0175","first-page":"278","article-title":"Calgary Depresyon Olceginin sizofreni hastalar\u0131nda gecerlik ve guvenirlilik \u00e7al\u0131\u015fmas\u0131","volume":"11","author":"Oksay","year":"2000","journal-title":"T\u00fcrk Psikiyatri Dergisi"},{"key":"10.1016\/j.schres.2018.12.015_bb0180","first-page":"97","article-title":"The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling","volume":"24","author":"Overall","year":"1988","journal-title":"Psychopharmacol. Bull."},{"issue":"5","key":"10.1016\/j.schres.2018.12.015_bb0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"17\u201318","key":"10.1016\/j.schres.2018.12.015_bb0195","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100\u202fyears in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.schres.2018.12.015_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(90)90003-N","article-title":"Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects","volume":"34","author":"Rao","year":"1990","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40501-016-0075-8","article-title":"Treating negative symptoms in schizophrenia: an update","volume":"3","author":"Remington","year":"2016","journal-title":"Curr. Treat. Options Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.015_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.156.1.79","article-title":"Olanzapine versus haloperidol treatment in first-episode psychosis","volume":"156","author":"Sanger","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2018.12.015_bb0215","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1046\/j.1471-4159.1996.67041761.x","article-title":"Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine","volume":"67","author":"Sastre","year":"1996","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"issue":"5 pt 2","key":"10.1016\/j.schres.2018.12.015_bb0225","first-page":"F1288","article-title":"Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus","volume":"258","author":"Segal","year":"1990","journal-title":"Am. J. Phys."},{"issue":"6","key":"10.1016\/j.schres.2018.12.015_bb0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.133.2.197","article-title":"The dopamine hypothesis of schizophrenia: focus on the dopamine receptor","volume":"133","author":"Snyder","year":"1976","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.12.015_bb0240","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2007.02.011","article-title":"Alterations in serum amino acid concentrations in male and female schizophrenic patients","volume":"380","author":"Tomiya","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"30","key":"10.1016\/j.schres.2018.12.015_bb0245","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.2174\/092986712803530601","article-title":"A new target for diagnosis and treatment of CNS disorders: agmatinergic system","volume":"19","author":"Uzbay","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.schres.2018.12.015_bb0250","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881109102533","article-title":"Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats","volume":"24","author":"Uzbay","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2018.12.015_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2009.12.020","article-title":"Sex-related effects of agmatine on caffeine-induced locomotor activity in Swiss Webster mice","volume":"630","author":"Uzbay","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.schres.2018.12.015_bb0260","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jpsychires.2013.04.004","article-title":"Increased plasma agmatine levels in patients with schizophrenia","volume":"47","author":"Uzbay","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0265","first-page":"544","article-title":"Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.schres.2018.12.015_bb0270","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1039\/C1MB05350G","article-title":"LC-MS-based metabolomics","volume":"8","author":"Zhou","year":"2012","journal-title":"Mol. BioSyst."},{"issue":"6\u20138","key":"10.1016\/j.schres.2018.12.015_bb0275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neuint.2008.09.001","article-title":"Repeated immobilization stress alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels","volume":"53","author":"Zhu","year":"2008","journal-title":"Neurochem. Int."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418307060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418307060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T16:34:40Z","timestamp":1558542880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418307060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":54,"alternative-id":["S0920996418307060"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"l-Arginine metabolism before and after 10\u202fweeks of antipsychotic treatment in first-episode psychotic patients","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}